Panmacular Versus Minimal Micropulse Laser Therapy in Central Serous Chorioretinopathy
Comparison of Panmacular Versus Minimal Micropulse Laser Therapy in Central Serous Chorioretinopathy
Sponsor: Chang Gung Memorial Hospital
This NA trial investigates Central Serous Chorioretinopathy and is currently ongoing. Chang Gung Memorial Hospital leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jul 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Jul 2022 [monthly]
Recruiting NA
-
Jul 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Jun 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chang Gung Memorial Hospital
- Moorfields Eye Hospital Centre Abu Dhabi
- The Filatov Institute of Eye Diseases and Tissue Therapy
- University of Gdansk
- University of Warmia and Mazury in Olsztyn
For direct contact, visit the study record on ClinicalTrials.gov .